Introduction: Early-onset obsessive-compulsive disorder (EOCD) and late-onset obsessive-compulsive disorder (LOCD) are distinct subtypes of obsessive-compulsive disorder. EOCD patients respond poorer to pharmacotherapy with serotonin reuptake inhibitors (SRIs) blocking serotonin transporters (SERTs). Still, there has been no study investigating two subgroups who are under pharmacotherapy. The aim of this study was to compare SERT binding potentials (BPs) using [
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Influence of age of onset on serotonin transporters of obsessive-compulsive Abstract Introduction: Early-onset obsessive-compulsive disorder (EOCD) and late-onset obsessive-compulsive disorder (LOCD) are distinct subtypes of obsessive-compulsive disorder. EOCD patients respond poorer to pharmacotherapy with serotonin reuptake inhibitors (SRIs) blocking serotonin transporters (SERTs). Still, there has been no study investigating two subgroups who are under pharmacotherapy. The aim of this study was to compare SERT binding potentials (BPs) using [ 11 C]DASB PET in EOCD and LOCD patients currently taking escitalopram. Methods: Six EOCD patients whose age of onset was <17 years and six LOCD patients whose age of onset ≥17 years were enrolled. They underwent serial PET scans during maintenance therapy with escitalopram and their plasma concentration of escitalopram was measured simultaneously with the scan. Drug-free BPs were obtained from an E max modelling we previously developed. Results: SERT availability was significantly different between subgroups in putamen (t=2.386, p=0.038), but not in caudate nucleus (t=0.740, p=0.476), thalamus (t=0.019, p=0.985), and dorsal raphe nucleus (t=1.658, p=0.128). Drug-free BPs of putamen had a negative correlation (r=-0.580, p=0.048) with age of onset of the disease, but not with the YBOCS scores. Conclusions: SERT availability was higher in putamen of EOCD patients than LOCD, and negatively correlated to the age of onset, in putamen of OCD patients. The finding suggests less extent of serotonergic pathology in younger EOCD patients even after long-term pharmacotherapy and that the non-SRI therapies would be a better option for them.
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Both chronic SSRI administration and serotonin depletion impairs context conditioned freezing behaviour
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Abstract Objective: The net influence of chronic administration of selective serotonin reuptake inhibitors (SSRIs) on serotonergic output remains unclear, some arguing that these drugs exert an antidepressant and anxiety-reducing effect by facilitating serotonergic output, and others suggesting that they, on the contrary, dampen an anxiogenic influence of this transmitter (e.g. by inducing a compensatory reduction in tph2 activity in serotonergic neurons or by down-regulating post-synaptic serotonergic receptors). In order to explore the latter possibility, we have compared the effect of subchronic SSRI administration with that of serotonin depletion in an animal model of anxiety, i.e. context-conditioned freezing behaviour. Methods: Male Sprague-Dawley rats were tested in a contextconditioning paradigm, where freezing behaviour was assessed as a putative measure of anxiety. The rats received a series of 10 inescapable electric foot-shocks in conditioning chambers, and freezing behaviour was scored on the following day when animals were reintroduced to the same testing apparatus. Prior to this procedure, rats had either been subjected to 18 days of escitalopram (admixed into food pellets) or to 3 days of i.p. injections of the serotonin synthesis inhibitor para-chlorophenylalanine (PCPA) (300 mg/kg/day). Results: Both animals treated with para-chlorophenylalanine and those given escitalopram displayed significantly less freezing as compared to controls.
Conclusion:
The results support the hypothesis that repeated administration of SSRIs exerts an anxiolytic influence by downregulating an anxiogenic influence of serotonin.
